National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
Clinical Trials (PDQ®)
Patient VersionHealth Professional Version
Last Modified: 3/31/2009     First Published: 5/23/2003  
Page Options
Print This Page  Print This Page
E-Mail This Document  E-Mail This Document
Clinical Trial Questions?

Get Help:

1-800-4-CANCER or

LiveHelp online chat

Quick Links
Help Using the NCI Clinical Trials Search Form

Educational Materials About Clinical Trials

About NCI's Cancer Clinical Trials Registry

Dictionary of Cancer Terms

NCI Drug Dictionary
Related Links
Educational Materials About Clinical Trials

Clinical Trials

Questions to Ask Your Doctor

Drug Information from MedlinePlus
Diagnostic and Genetic Study to Identify Pancreatic Lesions in Patients With Von Hippel-Lindau Syndrome

Alternate Title
Basic Trial Information
Trial Description
     Purpose
     Eligibility
     Treatment/Intervention
Trial Contact Information
Registry Information

Alternate Title

Natural History and Genetic Study of Patients With Von Hippel-Lindau Syndrome and Pancreatic Lesions

Basic Trial Information

PhaseTypeStatusAgeSponsorProtocol IDs
No phase specifiedBiomarker/Laboratory analysis, Diagnostic, Natural history/EpidemiologyClosed12 and overNCINCI-03-C-0145
NCT00062166

Trial Description

Purpose:

Diagnostic procedures such as CT scans and MRI may improve the identification of pancreatic lesions in patients who have von Hippel-Lindau syndrome. Genetic studies may help in understanding the genetic processes involved in the development of some types of cancer.

This clinical trial is studying how well diagnostic and genetic tests work in finding pancreatic lesions in patients with Von Hippel-Lindau syndrome.

Eligibility:

Eligibility criteria include the following:

Final eligibility for a clinical trial is determined by the health professionals conducting the trial.

Treatment/Intervention:

Patients will undergo imaging procedures, such as CT scan, MRI, and abdominal ultrasound. They will provide blood and urine samples for laboratory and genetic studies. All patients will be offered genetic counseling. Patients may undergo follow-up imaging procedures every 1-2 years. Some patients may undergo surgery.

Important:

For more details about this trial, refer to the Health Professional version of the trial summary.

If you are interested in participating in a clinical trial, contact your doctor for a referral or call a trial contact person listed below. You may see the same contact person listed at more than one site, however, if you call the number listed you can ask to speak to the study coordinator or person involved with the specific trial you are interested in. If you have questions about cancer or clinical trials, call the Cancer Information Service at 1-800-4-CANCER (1-800-422-6237). General information about clinical trials, including risks, benefits, and costs, can be found on NCI's Web site.

Trial Contact Information

Trial Lead Organizations

NCI - Center for Cancer Research

Steven Rosenberg, MD, PhD, Principal investigator
Ph: 301-496-4164
Email: sar@nih.gov

Registry Information
Official Title Evaluation of the Natural History and Management of Pancreatic Lesions Associated with Von Hippel-Lindau
Trial Start Date 2003-04-11
Registered in ClinicalTrials.gov NCT00062166
Date Submitted to PDQ 2003-04-28
Information Last Verified 2008-11-30

Back to TopBack to Top

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov